Cargando…
Radiogenomics predicts the expression of microRNA-1246 in the serum of esophageal cancer patients
Radiogenomics is a new field that provides clinically useful prognostic predictions by linking molecular characteristics such as the genetic aberrations of malignant tumors with medical images. The abnormal expression of serum microRNA-1246 (miR-1246) has been reported as a prognostic factor of esop...
Autores principales: | Hoshino, Isamu, Yokota, Hajime, Ishige, Fumitaka, Iwatate, Yosuke, Takeshita, Nobuyoshi, Nagase, Hiroki, Uno, Takashi, Matsubara, Hisahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018689/ https://www.ncbi.nlm.nih.gov/pubmed/32054931 http://dx.doi.org/10.1038/s41598-020-59500-7 |
Ejemplares similares
-
Cell-free microRNA-1246 in different body fluids as a diagnostic biomarker for esophageal squamous cell carcinoma
por: Hoshino, Isamu, et al.
Publicado: (2021) -
Usefulness of serum miR-1246/miR-106b ratio in patients with esophageal squamous cell carcinoma
por: Hoshino, Isamu, et al.
Publicado: (2020) -
Prediction of the differences in tumor mutation burden between primary and metastatic lesions by radiogenomics
por: Hoshino, Isamu, et al.
Publicado: (2021) -
MIR1246 in body fluids as a biomarker for pancreatic cancer
por: Ishige, Fumitaka, et al.
Publicado: (2020) -
Radiogenomics for predicting p53 status, PD-L1 expression, and prognosis with machine learning in pancreatic cancer
por: Iwatate, Yosuke, et al.
Publicado: (2020)